5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150 - Travis, MJ; Busatto, GF; Pilowsky, LS (Br J Psychiatry, 1998)
et al.